Posaconazole

This classification denotes an antifungal agent with the molecular formula C37H42F2N8O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6TK1G07BHZ, chemically known as d-threo-pentitol, 2,5-anhydro-1,3,4-trideoxy-2-c-(2,4-difluorophenyl)-4-((4-(4-(4-(1-((1s,2s)-1-etyl-2-hydroxypropyl)-1,5-dihydro-5-oxo-4h-1,2,4-triazol-4-yl)phenyl)-1-piperazinyl)phenoxy)methyl)-1-(1h-1,2,4-triazol-1-yl)- but generally known as posaconazole, which bears US NIH Compound Identifier 147912. European Medicines Agency schedules Posaconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20322. The term POSACONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). World Health Organization schedules posaconazole in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule posaconazole under HS 29349990 and SITC 51579. As of Q4 2014, POSACONAZOLE remains the US FDA Preferred Term for this commodity. Posaconazole bears US NLM identifiers UMLS ID C0936148 and NCI Concept Code C61500. SMILES: FC1C(C2(OCC(C2)COC2CCC(N3CCN(CC3)C3CCC(N4C(=O)N(NC4)C(C(O)C)CC)CC3)CC2)CN2NCNC2)CCC(F)C1.